top of page
Executive Spotlights

Michael Rossi has been named the new CEO of Y-mAbs Therapeutics

New York, NY, October 18, 2023 (Globe Newswire) -- Y-mAbs Therapeutics, Inc. (Nasdaq: YMAB) has named Michael Rossi as President and CEO, effective November 6, 2023. Rossi will also join the company's Board of Directors. Y-mAbs focuses on developing and commercializing antibody-based therapeutic products for cancer treatment.

Read full article here.

Recent Posts

See All

R3 Vascular Raises $87M in Series B Financing

Mountain View, CA, May 20, 2024 (FinSMEs) -- R3 Vascular, a medical device firm headquartered in California, secured $87 million in Series B financing. The funding round, spearheaded by Deerfield Ma


Life Science Headlines
bottom of page